Uric Acid Nephrolithiasis

• CLINICAL_TRIALS trial_result · 2026-01-30
  Clinical Trial Update: Phentermine/Topiramate for Uric Acid Stones [Phase 3]

  A Phase 3 trial evaluating the obesity drug combination phentermine/topiramate for uric acid nephrolithiasis has completed, with results pos…

• CLINICAL_TRIALS trial_result · 2025-09-09
  Clinical Trial Update: Pathogenesis of Uric Acid Nephrolithiasis: Role of Pioglitazone/Weight Loss [Phase 4]

  Phase 4 clinical trial evaluating the role of pioglitazone and weight loss in the pathogenesis of uric acid nephrolithiasis (completed).

• FDA approval · 2025-02-11
  FDA Approved: ALLOPURINOL — Supplemental Application (Accord Healthcare Inc.)

  FDA approved a supplemental application for Allopurinol from Accord Healthcare Inc., indicating an additional approval for the generic produ…

• CLINICAL_TRIALS trial_result · 2024-12-11
  Clinical Trial Update: Pathophysiology of Uric Acid Nephrolithiasis [NA]

  This Clinical Trial Update reports on the pathophysiology of uric acid nephrolithiasis, with the UT Southwestern study having completed.

• FDA approval · 2024-02-16
  FDA Approved: ALLOPURINOL — Supplemental Application (Par Health USA, LLC)

  The FDA approved a supplemental application for Allopurinol submitted by Par Health USA, LLC.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2024-02-05
  FDA Approved: ALLOPURINOL — Supplemental Application (Zydus Lifesciences Limited)

  FDA approved a supplemental application for ALLOPURINOL (Allopurinol) submitted by Zydus Lifesciences Limited, authorizing changes to the ap…

• FDA approval · 2022-08-08
  FDA Approved: ALLOPURINOL — Supplemental Application (Gland Pharma Limited)

  FDA approved a supplemental application from Gland Pharma Limited for Allopurinol, enabling the marketing of a generic Allopurinol product u…

• FDA approval · 2022-08-04
  FDA Approved: ALLOPURINOL — Supplemental Application (Rising Pharma Holdings, Inc.)

  The FDA approved a supplemental application for allopurinol submitted by Rising Pharma Holdings, Inc. This action authorizes a post-approval…

• FDA approval · 2022-01-26
  FDA Approved: ALLOPURINOL — Original Application (Gland Pharma Limited)

  FDA approved the original application for allopurinol from Gland Pharma Limited, enabling a generic version in the United States.

• FDA approval · 2020-08-28
  FDA Approved: ALOPRIM — Supplemental Application (Mylan Institutional LLC)

  FDA approved a supplemental application for ALOPRIM (allopurinol) submitted by Mylan Institutional LLC. The action relates to updates in the…

• CLINICAL_TRIALS trial_result · 2018-03-12
  Clinical Trial Update: Toxicity of Perirenal Fat in Overweight or Obese Subjects: A Pathophysiological Link Between Uric Acid Stones and Renal Ammonium Formation [NA]

  This clinical trial update reports on the toxicity of perirenal fat in overweight or obese individuals and a proposed pathophysiological lin…

• FDA approval · 2016-09-09
  FDA Approved: ALLOPURINOL SODIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved a supplemental application for Allopurinol Sodium (generic) from Hikma Pharmaceuticals USA Inc. under an ANDA.

• FDA approval · 2015-05-13
  FDA Approved: ALOPRIM — Supplemental Application (Mylan Institutional LLC)

  The FDA approved a supplemental application for ALOPRIM (allopurinol) submitted by Mylan Institutional LLC, resulting in updated labeling.

• FDA approval · 2013-05-06
  FDA Approved: ALLOPURINOL — Original Application (Accord Healthcare Inc.)

  FDA approved Accord Healthcare's original application for the generic drug allopurinol. Allopurinol is used to treat gout and to lower uric …